Customize your search results with filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 01/20/2023

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1207 publications

A multicenter, phase II study of full-dose THP-COP therapy for elderly patients with newly diagnosed, advanced-stage, aggressive non-Hodgkin lymphoma.

Condition: Elderly Patients with Advanced-Stage, Aggressive Non-Hodgkin Lymphoma (NHL)
Journal: Journal of clinical and experimental hematopathology : JCEH
Treatment Used: Pirarubicin and Modified CHOP Regimen (THP-COP)
Published: December 27, 2022

Safety and Efficacy of Humanized Versus Murinized CD19 and CD22 CAR T-Cell Cocktail Therapy for Refractory/Relapsed B-Cell Lymphoma.

Condition: Refractory/Relapsed (R/R) B-Cell Lymphoma
Journal: Cells
Treatment Used: Humanized Versus Murinized CD19 and CD22 CAR T-Cell Cocktail Therapy
Number of Patients: 126
Published: December 23, 2022

Next-Generation Chimeric Antigen Receptor T-cells.

Condition: B-Cell Non-Hodgkin Lymphoma (NHL) and Multiple Myeloma (MM)
Journal: Hematology/oncology and stem cell therapy
Treatment Used: CAR T-Cell Therapy
Published: December 20, 2022

Chimeric Antigen Receptor T-cell Therapies in Lymphoma Patients with Central Nervous System Involvement.

Condition: Central Nervous System (CNS) Lymphoma
Journal: Hematology/oncology and stem cell therapy
Treatment Used: CAR T-Cell Therapy
Number of Patients: 58
Published: December 20, 2022

Rapid response in relapsed follicular lymphoma with massive chylous ascites to anti-CD19 CAR T therapy using Piggy Bac: A case report.

Condition: Relapsed Follicular Lymphoma with Massive Chylous Ascites
Journal: Frontiers in immunology
Treatment Used: Anti-CD19 CAR T-Cell Therapy
Number of Patients: 1
Published: December 19, 2022

Burkitt lymphoma.

Condition: Burkitt Lymphoma (BL)
Journal: Nature reviews. Disease primers
Treatment Used: Chemotherapy
Published: December 15, 2022

A retrospective study of 18 children with subcutaneous panniculitis-like T-cell lymphoma: multidrug combination chemotherapy or immunomodulatory therapy?

Condition: Children with Subcutaneous Panniculitis T-Cell Lymphoma (SPTCL)
Journal: Orphanet journal of rare diseases
Treatment Used: Multidrug Combination Chemotherapy vs. Immunomodulatory Therapy
Number of Patients: 18
Published: December 12, 2022

Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma.

Condition: Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Journal: The New England journal of medicine
Treatment Used: Glofitamab
Number of Patients: 155
Published: December 12, 2022

Zanubrutinib plus salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma.

Condition: Diffuse Large B-Cell Lymphoma (DLBCL)
Journal: Frontiers in immunology
Treatment Used: Zanubrutinib Plus Salvage Chemotherapy
Number of Patients: 27
Published: December 12, 2022

Efficacy Analysis of Bendamustine-Based Combination Regimen in Treatment of Patients with Relapsed/Refractory Non-Hodgkin Lymphoma.

Condition: Relapsed/Refractory Non-Hodgkin Lymphoma
Journal: Zhongguo shi yan xue ye xue za zhi
Treatment Used: Bendamustine-Based Combination Regimen
Number of Patients: 18
Published: December 08, 2022

High-dose extended-field radiotherapy plus chemotherapy improved survival in extranodal NK/T-cell lymphoma in a real-life setting: results from the multicenter T-Cell Brazil Project.

Condition: Extranodal NK/T-Cell Lymphoma (ENKTL)
Journal: Scientific reports
Treatment Used: High-Dose Extended-Field Radiotherapy Plus Chemotherapy
Number of Patients: 98
Published: November 29, 2022

Targeting the CD47-SIRPα Axis: Present Therapies and the Future for Cutaneous T-cell Lymphoma.

Condition: Cutaneous T-cell Lymphoma
Journal: Cells
Treatment Used: Targeted anti-CD47 therapies
Published: November 26, 2022
Showing 1-12 of 1,207

Last Updated: 01/20/2023